RightFit Trial Directory

Colorectal Cancer clinical trials in Chicago, IL

36 recruiting colorectal cancer studies with a site in Chicago, IL.

All trials in Chicago, IL · All Colorectal Cancer trials

RecruitingPhase 3NCT07525206

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

Sponsor: AbbVie

Chicago, IL · +17 more sites

RecruitingPhase 2NCT07595874

Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3

Sponsor: City of Hope Medical Center

Chicago, IL · Zion, IL · +9 more sites

RecruitingPhase 2NCT07023289

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Sponsor: AbbVie

Chicago, IL · +21 more sites

RecruitingPhase 3NCT07222800

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Sponsor: Pfizer

Arlington Heights, IL · Bloomington, IL · Chicago, IL · +251 more sites

RecruitingPhase not listedNCT03998202

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

Sponsor: Wake Forest University Health Sciences

Bloomington, IL · Canton, IL · Carterville, IL · +144 more sites

RecruitingPhase 3NCT07228832

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Sponsor: Summit Therapeutics

Chicago, IL · Elmhurst, IL · +109 more sites

RecruitingPhase 1NCT07416552

A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

Sponsor: Hoffmann-La Roche

Chicago, IL · +4 more sites

RecruitingPhase 2NCT07446322

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

Sponsor: Oncolytics Biotech

Chicago, IL · +16 more sites

RecruitingPhase 1NCT07454642

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

Sponsor: Avacta Life Sciences Ltd

Chicago, IL · +6 more sites

RecruitingNot applicableNCT05612347

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

Sponsor: Dartmouth-Hitchcock Medical Center

Chicago, IL · +19 more sites

RecruitingPhase 2NCT05673148

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Sponsor: Alliance for Clinical Trials in Oncology

Chicago, IL · +187 more sites

RecruitingPhase 1NCT06004245

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

Sponsor: Vividion Therapeutics, Inc.

Chicago, IL · +15 more sites

RecruitingPhase 1NCT06218914

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Sponsor: AstraZeneca

Chicago, IL · +17 more sites

RecruitingPhase 3NCT05863195

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Sponsor: ECOG-ACRIN Cancer Research Group

Chicago, IL · +59 more sites

RecruitingPhase 1 / Phase 2NCT06349590

Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery

Sponsor: University of Chicago

Chicago, IL

RecruitingPhase 3NCT06252649

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

Sponsor: Amgen

Chicago, IL · Hinsdale, IL · Skokie, IL · +23 more sites

RecruitingPhase 1 / Phase 2NCT04851119

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Sponsor: Children's Oncology Group

Chicago, IL · +20 more sites

RecruitingPhase 2NCT06792695

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Sponsor: AstraZeneca

Chicago, IL · +13 more sites

RecruitingPhase not listedNCT06880055

Shield Post-Approval Study Protocol

Sponsor: Guardant Health, Inc.

Bourbonnais, IL · Champaign, IL · +66 more sites

RecruitingPhase 1NCT05433142

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Sponsor: Xencor, Inc.

Chicago, IL · +18 more sites

RecruitingPhase 2NCT06937177

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

Sponsor: Endevica Bio

Chicago, IL · Hinsdale, IL · Skokie, IL · +22 more sites

RecruitingPhase not listedNCT06698146

Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection

Sponsor: Northwestern University

Chicago, IL

RecruitingPhase 1 / Phase 2NCT07169734

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

Sponsor: Alentis Therapeutics AG

Chicago, IL · +8 more sites

RecruitingPhase 1NCT06756035

CT-95 in Advanced Cancers Associated With Mesothelin Expression

Sponsor: Context Therapeutics Inc.

Chicago, IL · +8 more sites

RecruitingPhase 1NCT05283330

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Sponsor: Orano Med Theranostics, SAS

Chicago, IL · +7 more sites

RecruitingPhase 3NCT06950385

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

Sponsor: Rapamycin Holdings Inc.

Chicago, IL · +17 more sites

RecruitingPhase not listedNCT05732623

Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer

Sponsor: San Raffaele University

Chicago, IL · +1 more sites

RecruitingPhase not listedNCT06898996

FITting Non-invasive Tests in Lynch Syndrome Surveillance

Sponsor: University of Chicago

Chicago, IL · +2 more sites

RecruitingPhase 1 / Phase 2NCT06395519

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Sponsor: 858 Therapeutics, Inc.

Chicago, IL · +13 more sites

RecruitingPhase not listedNCT04857528

Detecting HPV DNA in Anal and Cervical Cancers

Sponsor: University of Chicago

Chicago, IL

RecruitingPhase 1NCT06778863

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Sponsor: Clasp Therapeutics, Inc.

Chicago, IL · +20 more sites

RecruitingPhase 1 / Phase 2NCT06055439

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

Sponsor: Chimeric Therapeutics

Chicago, IL · +3 more sites

RecruitingPhase 4NCT04373564

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Sponsor: Guerbet

Chicago, IL · Peoria, IL · +14 more sites

RecruitingPhase not listedNCT06073431

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Sponsor: University of Rochester

Alton, IL · Barrington, IL · Bloomington, IL · +222 more sites

RecruitingPhase 1NCT05107674

A Study of NX-1607 in Adults With Advanced Malignancies

Sponsor: Nurix Therapeutics, Inc.

Chicago, IL · +9 more sites

Not yet recruitingPhase not listedNCT07211230

Collagenase Biobank Study

Sponsor: University of Chicago

Chicago, IL

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.